These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 728687)

  • 1. The effects of dorsal bundle injections of 6-hydroxydopamine on avoidance responding in rats.
    Fibiger HC; Mason ST
    Br J Pharmacol; 1978 Dec; 64(4):601-5. PubMed ID: 728687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of intra-amygdaloid injections of 6-hydroxy-dopamine on avoidance responding in rats.
    Ashford J; Jones BJ
    Br J Pharmacol; 1976 Mar; 56(3):255-61. PubMed ID: 1260169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of brain noradrenaline and the pituitary-adrenal axis in learning and extinction.
    Mason ST; Roberts DC; Fibiger HC
    Pharmacol Biochem Behav; 1979 Jan; 10(1):11-6. PubMed ID: 441087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of active avoidance of responding after lateral hypothalamic injections of 6-hydroxydopamine.
    Smith GP; Levin BE; Ervin GN
    Brain Res; 1975 May; 88(3):483-98. PubMed ID: 1139290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of the intracisternal administration of the neurotoxins 6-hydroxydopamine and 5,7-dihydroxytryptamine on the formation of the passive avoidance reaction and the biogenic amine level in the brain of rats].
    Shabanov PD; Bul'on VV; Lénárd L
    Fiziol Zh SSSR Im I M Sechenova; 1988 Jul; 74(7):920-3. PubMed ID: 3141223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of central catecholamine alterations by 6-hydroxydopamine on shuttle box avoidance acquistion.
    Cooper BR; Breese GR; Howard JL; Grant LD
    Physiol Behav; 1972; 9(5):727-31. PubMed ID: 4655165
    [No Abstract]   [Full Text] [Related]  

  • 7. Aversive effects of subcutaneously injected vasopressin in the rat: independence of the ascending dorsal noradrenergic bundle.
    Tam FW; Chen C; Alpert JE; Iversen SD
    Brain Res; 1985 Jun; 337(1):133-7. PubMed ID: 3924347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminated escape learning and response to electric shock after 6-hydroxydopamine lesions of the nigro-neostriatal dopaminergic projection.
    Price MT; Fibiger HC
    Pharmacol Biochem Behav; 1975; 3(2):285-90. PubMed ID: 1096176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Learning impairments after 6-OHDA treatment: a comparison with the effects of thiamine deficiency.
    Anderson CD; Mair RG; Langlais PJ; McEntee WJ
    Behav Brain Res; 1986 Jul; 21(1):21-7. PubMed ID: 3091046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noradrenaline and avoidance learning in the rat.
    Mason ST; Fibiger HC
    Brain Res; 1979 Feb; 161(2):321-33. PubMed ID: 758978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical basis of the dorsal bundle extinction effect.
    Mason ST; Fibiger HC
    Pharmacol Biochem Behav; 1979 Mar; 10(3):373-80. PubMed ID: 450950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of brain levels of norepinephrine and dopamine to avoidance behavior in rats after intraventricular administration of 6-hydoxydopamine.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):895-9. PubMed ID: 1208632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-OHDA lesion of the dorsal noradrenergic bundle alters extinction of passive avoidance.
    Mason ST; Fibiger HC
    Brain Res; 1978 Aug; 152(1):209-14. PubMed ID: 679025
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence for interactions between central noradrenergic neurons and adrenal hormones in learning and memory.
    Roberts DC; Fibiger HC
    Pharmacol Biochem Behav; 1977 Sep; 7(3):191-4. PubMed ID: 200962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dorsal noradrenergic bundle and varieties of passive avoidance.
    Mason ST; Fibiger HC
    Psychopharmacology (Berl); 1979 Nov; 66(2):179-82. PubMed ID: 119260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of avoidance behavior in 6-hydroxydopamine-treated rats by stimulation of central noradrenergic and dopaminergic receptors.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):887-93. PubMed ID: 1208631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR; Breese GR; Grant LD; Howard JL
    J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
    [No Abstract]   [Full Text] [Related]  

  • 18. Contribution of forebrain noradrenaline innervation to the central circulatory effects of alpha-methyldopa and 6-hydroxydopamine.
    van den Buuse M; Head GA; Korner PI
    Brain Res; 1991 Feb; 541(2):300-8. PubMed ID: 1905177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of brain noradrenaline, but not dopamine, by intracerebral 6-hydroxydopamine potentiates convulsions induced by electroshock.
    Mason ST; Corcoran ME
    J Pharm Pharmacol; 1979 Apr; 31(4):209-11. PubMed ID: 36457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exaggerated avoidance of novel stimulation in rats partially recovered from central norepinephrine damage.
    Bresler DE; Diaz J; Ellison G
    Pharmacol Biochem Behav; 1976 Mar; 4(3):343-6. PubMed ID: 935205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.